Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3751–3800 of 33040
On February 28, 2025, each of Charles Benton and Judd Brammah notified Vision Energy Corporation (the “Company”) of his resignation as a director of the Company, effective immediately.
On February 28, 2025, each of Charles Benton and Judd Brammah notified Vision Energy Corporation (the “Company”) of his resignation as a director of the Company, effective immediately.
Effective February 28, 2025, Mr. Robert Feitler resigned from his position as a member of the Board of Directors (“Board”) of Weyco Group, Inc. (the “Company”).
Patrick A. Luis, Chief Credit Officer of Community West Bank (the "Bank"), notified the Bank of his decision to resign from his position with the Bank, effective February 28, 2025.
Patrick A. Luis, Chief Credit Officer of Community West Bank (the “Bank”), notified the Bank of his decision to resign from his position with the Bank, effective February 28, 2025.
On March 5, 2025, Ultra Clean Holdings, Inc. (the “Company”) issued a press release announcing that James P. Scholhamer has resigned, effective March 4, 2025, as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors
In conjunction with the execution of this consulting agreement, Mr. Kang resigned from the Board for personal reasons, effective as of March 3, 2025.
On February 28, 2025, Jiyoung Hwang resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) for personal reasons, effective immediately as of such date.
On March 5, 2025, Certara, Inc. (the “Company”) announced that Dr. Patrick F. Smith, President, Certara Drug Development Solutions, stepped down from that role as of March 3, 2025, but will remain employed by the Company in a senior advisory and scientific role.
The February 27, 2025, resignation of Ellis Smith was accepted by the Board at this meeting.
The Company also announces that John R. Blind, a member of the Board and the lead independent director, is retiring at the expiration of his current term when a new director is elected at the Company’s 2025 Annual Meeting of Shareholders in July.
The Company previously announced the retirement of Ronald M. Graham effective February 28, 2025.
The Company previously announced the retirement of Terry Pennington effective February 28, 2025.
On February 26, 2025, Michael S. Liebowitz notified the Board of Directors (the “ Board ”) of Nocopi Technologies, Inc. (the “ Company ”) of his resignation as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.
On March 4, 2025, ProPetro Holding Corp. (the “Company”) announced the departure of David S. Schorlemer from his role as Chief Financial Officer of the Company, effective March 3 , 2025
On February 28, 2025, David B. Kagan notified the Company of his resignation as a member of the Company’s Board of Directors, effective February 28, 2025.
As part of its corporate restructuring announced on February 28, 2025, Adagio Medical Holdings, Inc. (the “Company”), announced the departure of Hakon Bergheim, the Company’s Chief Operating Officer, effective February 28, 2025.
On March 3, 2025, Anthony Coelho, a director of AudioEye, Inc. (the “Company”), notified the Company of his decision to resign as a director of the Company, effective on March 3, 2025.
Jeffrey Krumpoch, who ceased to serve as Interim Chief Accounting Officer, pending his retirement.
On February 28, 2025, Anthony Doyle, the Chief Financial Officer of BioCryst Pharmaceuticals, Inc. (the “Company”) notified the Company of his intention to resign from his employment with the Company, effective April 9, 2025.
William “Bill” Wagner, member of the board of directors (the “Board”) of BlackLine, Inc. (the “Company”) informed the Company that he intended to resign from the Board, effective as of the expected date of the Company’s annual stockholder meeting.
On February 28, 2025, Kathleen A. Murphy, a member of the Board of Directors (the “Board”) of Prudential Financial, Inc. (the “Company”), notified the Board that she will not stand for reelection to the Board at the Company’s next annual meeting of shareholders, to be held on May 13, 2025.
On March 3, 2025, Laura Gault, M.D., Ph.D. notified Sage Therapeutics, Inc. (the “Company”) of her decision to resign as Chief Medical Officer of the Company, effective March 21, 2025, to pursue a new opportunity.
On February 27, 2025, Catherine R. Smith, the Company’s Chief Financial Officer, informed the Company of her intention to step down from her role following the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2025, anticipated to be within the next month.
On February 28, 2025, Lourinda St. John, Chief Human Resources Officer of Acuren Corporation (the “Company”), notified the Company that, due to personal reasons, she intends to resign from her current title and roles at the Company and all of its subsidiaries effective April 7, 2025.
On March 2, 2025, the Company notified David Gustafson, Chief Operating Officer, that the Company had made a strategic decision to terminate Mr. Gustafson, effective immediately.
The planned departure of Ms. Mapes as Chief Legal & Administration Officer and Corporate Secretary of the Company is not due to any disagreement with the Company.
On February 26, 2025, FutureFuel Corp. (the “Company”) and Charles W. Lyon agreed to terminate his employment as Chief Commercial Officer of the Company to be effective as of March 31, 2025.
Nancy Duitch, voluntarily resigned from her position as Chief Executive Officer effective March 1, 2025.
On February 28, 2025, Alan Ramsay informed Maplebear Inc. (the “ Company ”) of his decision to resign from his position as the Company’s Chief Accounting Officer and principal accounting officer, effective as of March 10, 2025
On February 27, 2025, Judith A. McHale, a member of the Board of Directors (the “Board”) of Hilton Worldwide Holdings Inc. (the “Company”), notified the Company of her intention not to stand for re-election and to retire from the Board, effective May 13, 2025.
Peter Bains and Jo LeCouilliard have decided not to stand for re-election at the Company’s Annual General Meeting.
Peter Bains and Jo LeCouilliard have decided not to stand for re-election at the Company’s Annual General Meeting.
Robert Schriesheim notified the Board of his resignation therefrom on March 2, 2025 with immediate effect.
On February 26, 2025, Dr. Richard B. Miles tendered his resignation from the Board of Directors (the “ Board ”) of Precision Optics Corporation, Inc. (the “ Company ”) retiring from the Board effective as of February 28, 2025.
On February 28, 2025, Len Blackwell notified the Board of Directors of the Company that he would not stand for re-election at the Company’s 2025 annual meeting of stockholders.
On February 27, 2025, Ellis Smith resigned as a director and as president, secretary and treasurer of the Registrant and all subsidiaries.
On February 26, 2025, Bryan Johnson informed Vestis Corporation (the “Company”) of his resignation as Chief Accounting Officer of the Company, effective March 10, 2025.
On February 28, 2025, Gary Swidler, the Company’s President, gave notice to the Company of his intention to terminate his employment with the Company effective as of July 4, 2025.
On February 28, 2025, each of William M. Lewis, Jr., who currently serves as a Class II director on the Board of Directors (the “Board”) of ADT Inc. (the “Company”) with a term expiring at the Company’s 2025 Annual Meeting of Stockholders, and Lee J. Solomon, who currently serves as a Class I director on the Board with a term expiring at the Company’s 2027 Annual Meeting of Stockholders, retired from his position as a member of the Board.
On February 28, 2025, each of William M. Lewis, Jr., who currently serves as a Class II director on the Board of Directors (the “Board”) of ADT Inc. (the “Company”) with a term expiring at the Company’s 2025 Annual Meeting of Stockholders, and Lee J. Solomon, who currently serves as a Class I director on the Board with a term expiring at the Company’s 2027 Annual Meeting of Stockholders, retired from his position as a member of the Board.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Accordingly, the remaining ten individuals currently serving as directors will not stand for reelection at the Company’s 2025 annual meeting of shareholders, as follows: David H. Koppenhaver, George Snead, Lloyd Harrison, Mona Albertine, Steven I. Tressler, Jennifer Delaye, William L. Jones, James A. Tamburro, David Doane and John W. Breda.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.